ProPhase Labs Inc (PRPH)
0.7452
-0.02
(-3.08%)
USD |
NASDAQ |
Nov 25, 14:04
ProPhase Labs Enterprise Value: 35.03M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 35.03M |
| November 21, 2024 | 35.22M |
| November 20, 2024 | 34.94M |
| November 19, 2024 | 34.82M |
| November 18, 2024 | 35.47M |
| November 15, 2024 | 34.58M |
| November 14, 2024 | 34.61M |
| November 13, 2024 | 35.06M |
| November 12, 2024 | 34.28M |
| November 11, 2024 | 30.77M |
| November 08, 2024 | 31.56M |
| November 07, 2024 | 43.96M |
| November 06, 2024 | 53.69M |
| November 05, 2024 | 56.36M |
| November 04, 2024 | 58.46M |
| November 01, 2024 | 57.50M |
| October 31, 2024 | 60.36M |
| October 30, 2024 | 59.98M |
| October 29, 2024 | 59.60M |
| October 28, 2024 | 62.46M |
| October 25, 2024 | 62.27M |
| October 24, 2024 | 60.65M |
| October 23, 2024 | 60.56M |
| October 22, 2024 | 63.23M |
| October 21, 2024 | 62.46M |
| Date | Value |
|---|---|
| October 18, 2024 | 62.46M |
| October 17, 2024 | 63.23M |
| October 16, 2024 | 62.08M |
| October 15, 2024 | 60.27M |
| October 14, 2024 | 62.46M |
| October 11, 2024 | 62.65M |
| October 10, 2024 | 59.22M |
| October 09, 2024 | 60.36M |
| October 08, 2024 | 60.94M |
| October 07, 2024 | 63.80M |
| October 04, 2024 | 63.61M |
| October 03, 2024 | 62.46M |
| October 02, 2024 | 62.46M |
| October 01, 2024 | 59.60M |
| September 30, 2024 | 62.84M |
| September 27, 2024 | 57.59M |
| September 26, 2024 | 55.11M |
| September 25, 2024 | 53.02M |
| September 24, 2024 | 53.78M |
| September 23, 2024 | 57.21M |
| September 20, 2024 | 56.45M |
| September 19, 2024 | 59.69M |
| September 18, 2024 | 58.55M |
| September 17, 2024 | 61.98M |
| September 16, 2024 | 57.59M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
10.35M
Minimum
Jul 02 2020
211.63M
Maximum
Jul 11 2022
89.36M
Average
91.06M
Median
Feb 28 2024
Enterprise Value Benchmarks
| Fonar Corp | 41.10M |
| XWELL Inc | 0.382M |
| Applied DNA Sciences Inc | -9.003M |
| Veracyte Inc | 2.794B |
| OncoCyte Corp | 42.26M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.587M |
| Revenue (Quarterly) | 3.146M |
| Total Expenses (Quarterly) | 11.08M |
| EPS Diluted (Quarterly) | -0.35 |
| Gross Profit Margin (Quarterly) | -5.24% |
| Profit Margin (Quarterly) | -209.4% |
| Earnings Yield | -206.7% |
| Normalized Earnings Yield | -206.66 |